Examorelin

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameExamorelin
Drug Alias Nameexamorelinum艾莫瑞林艾沙瑞林examorelinaHexarelin +[7] 
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionGhrelin/growth hormone secretagogue receptor agonists
TargetsGhrelin/growth hormone secretagogue receptor
Therapy Area/IndicationsGrowth hormone deficiencyHeart Failure
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesMediolanum Farmaceutici Spa
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMediolanum Farmaceutici Spa
Active IndicationsN/A
Inactive IndicationsGrowth hormone deficiencyHeart Failure

Other Information

ATC CodeN/A
Related LinksWikipedia